Comerica Bank’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $8.89M | Sell |
104,324
-12,028
| -10% | -$987K | 0.04% | 390 |
|
|
2025
Q3 | $9.05M | Sell |
116,352
-3,603
| -3% | -$282K | 0.03% | 462 |
|
|
2025
Q2 | $9.38M | Sell |
119,955
-5,735
| -5% | -$428K | 0.04% | 447 |
|
|
2025
Q1 | $9.11M | Sell |
125,690
-572
| -0.5% | -$40.9K | 0.04% | 435 |
|
|
2024
Q4 | $9.35M | Sell |
126,262
-9,687
| -7% | -$678K | 0.04% | 434 |
|
|
2024
Q3 | $8.97M | Sell |
135,949
-31,106
| -19% | -$2.26M | 0.04% | 451 |
|
|
2024
Q2 | $15.4M | Sell |
167,055
-2,785
| -2% | -$247K | 0.06% | 288 |
|
|
2024
Q1 | $16.2M | Sell |
169,840
-7,206
| -4% | -$605K | 0.07% | 277 |
|
|
2023
Q4 | $13.5M | Sell |
177,046
-7,505
| -4% | -$522K | 0.06% | 314 |
|
|
2023
Q3 | $12.8M | Buy |
+184,551
| New | +$14.8M | 0.07% | 287 |
|
|
2022
Q4 | $11.7M | Buy |
148,819
+1,915
| +1% | +$148K | 0.09% | 227 |
|
|
2022
Q3 | $12.5M | Buy |
146,904
+1,481
| +1% | +$143K | 0.11% | 181 |
|
|
2022
Q2 | $14.7M | Sell |
145,423
-2,296
| -2% | -$238K | 0.12% | 136 |
|
|
2022
Q1 | $18.9M | Sell |
147,719
-2,823
| -2% | -$317K | 0.14% | 123 |
|
|
2021
Q4 | $16.5M | Sell |
150,542
-3,888
| -3% | -$454K | 0.12% | 140 |
|
|
2021
Q3 | $18M | Sell |
154,430
-26,619
| -15% | -$3.04M | 0.11% | 165 |
|
|
2021
Q2 | $21.4M | Sell |
181,049
-4,270
| -2% | -$402K | 0.13% | 133 |
|
|
2021
Q1 | $18.1M | Sell |
185,319
-2,358
| -1% | -$199K | 0.11% | 161 |
|
|
2020
Q4 | $16.1M | Sell |
187,677
-20,234
| -10% | -$1.68M | 0.1% | 174 |
|
|
2020
Q3 | $16.7M | Buy |
207,911
+8,124
| +4% | +$634K | 0.12% | 138 |
|
|
2020
Q2 | $15.6M | Buy |
199,787
+5,246
| +3% | +$373K | 0.12% | 145 |
|
|
2020
Q1 | $14.5M | Sell |
194,541
-3,882
| -2% | -$280K | 0.13% | 134 |
|
|
2019
Q4 | $15.5M | Sell |
198,423
-16,833
| -8% | -$1.31M | 0.12% | 157 |
|
|
2019
Q3 | $16.4M | Sell |
215,256
-1,878
| -0.9% | -$132K | 0.13% | 140 |
|
|
2019
Q2 | $13.7M | Buy |
217,134
+3,762
| +2% | +$227K | 0.11% | 169 |
|
|
2019
Q1 | $13.4M | Sell |
213,372
-6,108
| -3% | -$349K | 0.11% | 165 |
|
|
2018
Q4 | $12.2M | Sell |
219,480
-10,689
| -5% | -$541K | 0.1% | 193 |
|
|
2018
Q3 | $11.4M | Sell |
230,169
-43,776
| -16% | -$2.14M | 0.09% | 217 |
|
|
2018
Q2 | $13.6M | Sell |
273,945
-3,765
| -1% | -$176K | 0.1% | 216 |
|
|
2018
Q1 | $12.8M | Sell |
277,710
-13,074
| -4% | -$568K | 0.09% | 227 |
|
|
2017
Q4 | $12.1M | Sell |
290,784
-16,956
| -6% | -$622K | 0.08% | 264 |
|
|
2017
Q3 | $10.4M | Sell |
307,740
-1,329
| -0.4% | -$50.7K | 0.08% | 273 |
|
|
2017
Q2 | $12.1M | Sell |
309,069
-5,598
| -2% | -$204K | 0.09% | 222 |
|
|
2017
Q1 | $11.5M | Buy |
314,667
+23,799
| +8% | +$745K | 0.09% | 228 |
|
|
2016
Q4 | $9.42M | Buy |
290,868
+9,819
| +3% | +$318K | 0.07% | 268 |
|
|
2016
Q3 | $11.2M | Buy |
281,049
+1,125
| +0.4% | +$42.4K | 0.1% | 201 |
|
|
2016
Q2 | $10.6M | Sell |
279,924
-41,592
| -13% | -$1.42M | 0.09% | 206 |
|
|
2016
Q1 | $11.4M | Sell |
321,516
-33,393
| -9% | -$921K | 0.1% | 180 |
|
|
2015
Q4 | $9M | Sell |
354,909
-3,291
| -0.9% | -$85.5K | 0.09% | 221 |
|
|
2015
Q3 | $8.49M | Sell |
358,200
-394,812
| -52% | -$9.53M | 0.08% | 237 |
|
|
2015
Q2 | $17.9M | Buy |
753,012
+366,870
| +95% | +$8.28M | 0.08% | 254 |
|
|
2015
Q1 | $9.17M | Sell |
386,142
-372,282
| -49% | -$8.35M | 0.08% | 251 |
|
|
2014
Q4 | $16.1M | Buy |
758,424
+384,864
| +103% | +$7.73M | 0.07% | 279 |
|
|
2014
Q3 | $6.36M | Sell |
373,560
-13,854
| -4% | -$219K | 0.06% | 347 |
|
|
2014
Q2 | $5.54M | Sell |
387,414
-63,240
| -14% | -$857K | 0.05% | 429 |
|
|
2014
Q1 | $5.57M | Buy |
450,654
+38,802
| +9% | +$448K | 0.04% | 479 |
|
|
2013
Q4 | $4.51M | Sell |
411,852
-564,144
| -58% | -$6.36M | 0.04% | 578 |
|
|
2013
Q3 | $11.3M | Sell |
975,996
-58,230
| -6% | -$681K | 0.08% | 246 |
|
|
2013
Q2 | $11.6M | Buy |
+1,034,226
| New | +$12.2M | 0.09% | 211 |
|
Other funds holding EW
Comerica Bank's EW Position: Q4 2025 in Review
Comerica Bank reduced its Edwards Lifesciences (EW) stake by 10% in Q4 2025, selling an estimated $987K and leaving 104,324 shares worth $8.89M. The position accounts for 0.04% of the portfolio, ranked #390.
Comerica Bank first reported a position in EW in Q2 2013 and has held it in 49 quarters since. The position peaked at $21.4M in Q2 2021. 1,314 funds tracked by Wall St. Rank hold EW as of Q4 2025.
- Comerica Bank held 104,324 shares of Edwards Lifesciences worth $8.89M as of Q4 2025.
- Comerica Bank sold 12,028 Edwards Lifesciences shares in Q4 2025, an estimated $987K.
- Edwards Lifesciences made up 0.04% of Comerica Bank's portfolio in Q4 2025, its #390 holding.
- Comerica Bank first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 49 quarters since.
- Comerica Bank's Edwards Lifesciences position peaked at $21.4M in Q2 2021.
- 1,314 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.
Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.